Investing

First Look Analysts Research Calls for Thursday, January 19

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> CureVac (CVAC) upgraded to Buy from Neutral at UBS; tgt raised to $18

Downgrades:

> Cognizant Tech (CTSH) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $60

> DXC Technology (DXC) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $28

Others:

> Alpine Immune Sciences (ALPN) initiated with an Overweight at Morgan Stanley; tgt $17

> CF Industries (CF) initiated with an Overweight at Wells Fargo; tgt $110

> Corteva (CTVA) initiated with an Overweight at Wells Fargo; tgt $78

> FMC Corp (FMC) assumed with an Overweight at Wells Fargo; tgt $148

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.